Current Collaborators In 'industry partners' Current CollaboratorsHow to submit an asset for assessment and prioritisation for inclusion in Glo-BNHL? Back to 'Glo-BNHL' Current Glo-BNHL treatment arms: Bispecific antibody Odronextamab, Regeneron Pharmaceuticals Inc. Antibody Drug Conjugate Loncastuximab tesirine with standard chemotherapy, ADC Therapeutics SA